Data from Patrys' PAT-SM6 Phase I/IIa trial in multiple myeloma to be presented at ASH Annual Meeting

Patrys Limited , a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma will be presented at the 55th American Society of Hematology Annual Meeting in New Orleans, LA on 7- 10 December 2013.

http://www.news-medical.net/news/20131129/Data-from-Patrys-PAT-SM6-Phase-IIIa-trial-in-multiple-myeloma-to-be-presented-at-ASH-Annual-Meeting.aspx